Clinical Trial Update: High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT

View source ↗

Summary

The update reports that high-dose etoposide may help discriminate which patients with refractory or relapsed lymphoma benefit from autologous peripheral blood s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Etoposide (Etoposide)

Snippet

Sponsor: Yang Jun | Conditions: Lymphoma | Status: COMPLETED